Aethon Therapeutics
About:
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.
Website: https://aethontx.com
Top Investors: Apple Tree Partners, NYU Langone Health
Description:
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer-associated mutations.
Total Funding Amount:
$30M
Headquarters Location:
New York, New York, United States
Founded Date:
2022-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-01-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai